Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Ferrer, officially known as Ferrer Internacional, is a prominent global pharmaceutical and healthcare company headquartered in Spain. Established in 1959, Ferrer has made significant strides in the industry, focusing on the development of innovative solutions in pharmaceuticals, biotechnology, and consumer health. With a strong presence in Europe, Latin America, and Asia, the company is dedicated to improving patient outcomes through its diverse portfolio.
Ferrer’s core offerings include prescription medicines, over-the-counter products, and advanced biopharmaceuticals, distinguished by their commitment to quality and innovation. The company has achieved notable recognition for its research-driven approach and has established itself as a key player in the healthcare sector. With a focus on sustainability and social responsibility, Ferrer continues to enhance its market position while striving to meet the evolving needs of patients worldwide.
+34 vs industry average
Ferrer’s score of 66 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing has below-average carbon intensity
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Scope 3 accounts for ••• of total emissions.
In 2024, Ferrer reported total carbon emissions of approximately 75,138,200 kg CO2e, comprising 7,743,400 kg CO2e from Scope 1, 4,114,400 kg CO2e from Scope 2, and 67,394,800 kg CO2e from Scope 3 emissions. This represents a decrease from 2023, where total emissions were approximately 78,630,200 kg CO2e. The company has set ambitious climate commitments, aiming to achieve carbon neutrality in its direct emissions (Scope 1) by 2030 and across all emissions (Scope 1, 2, and 3) by 2050.
Ferrer has committed to reducing its absolute Scope 1 and 2 GHG emissions by 48.3% by 2030 from a 2019 baseline, while also targeting a 55% reduction in Scope 3 emissions per million EUR value added by the same year. Additionally, the company plans to source 100% renewable electricity by 2030. These targets align with the Science Based Targets initiative (SBTi) and are consistent with the reductions required to limit global warming to 1.5°C.
Ferrer’s long-term goals include a 90% reduction in absolute Scope 1 and 2 emissions by 2050 and a 97% reduction in Scope 3 emissions per million EUR value added. The company is actively working towards these targets, demonstrating a strong commitment to sustainability and climate action.
2050
90% reduction in Scope 1
Grupo Ferrer Internacional, S.A. commits to reduce absolute scope 1 GHG emissions 90% by 2050 from a 2019 base year.
2050
90% reduction in Scope 2
Grupo Ferrer Internacional, S.A. commits to reduce absolute scope 2 GHG emissions 90% by 2050 from a 2019 base year.
2030
48.3% reduction in Scope 2
Grupo Ferrer Internacional, S.A. commits to reduce absolute scope 2 GHG emissions 48.3% by 2030 from a 2019 base year.
See all 7 climate goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Ferrer’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more